Liver analysis using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging: Correlation with histological grading and quantitative liver evaluation prior to hepatectomy

Hepatology Research

Volumn 42, Issue 11, 2012, Pages 1081-1088

  Kumazawa, Keigo ^a   Edamoto, Yoshihiro ^a   Yanase, Mikio ^a   Nakayama, Tomohiro ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging; Intensity ratio; Liver fibrosis; Liver function test

Indexed keywords

COLLAGEN TYPE 4; GADOXETIC ACID; GALACTOSYLNEOGLYCOALBUMIN TC 99M; HYALURONIC ACID; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER FIBROSIS; LIVER FUNCTION; LIVER RESECTION; LIVER SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; SPINAL CORD;

EID: 84868021339     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01027.x     Document Type: Article

References (28)

1. Pares A, Deulofeu R, Gimenez A etal. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996; 24: 1399-403.
2. Murawaki Y, Ikuta Y, Koda M, Yamada S, Kawasaki H. Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease. J Hepatol 1996; 24: 148-54.
3. Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L. Contribution of the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis. Eur Radiol 2011; 21: 1233-24.
4. Shuter B, Tofts PS, Wang SC, Pope JM. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Magn Reson Imaging 1996; 14: 243-53.
5. Planchamp C, Gex-Fabry M, Dornier C etal. Gd-BOPTA transport into rat hepatocytes: pharmacokinetic analysis of dynamic magnetic resonance images using a hollow-fiber bioreactor. Invest Radiol 2004; 39: 506-15.
6. Kuwatsuru R, Brash RC, Mulher A etal. Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents. Radiology 1997; 202: 131-8.
7. Kim T, Murakami T, Hasuike Y etal. Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 1997; 7: 683-8.
8. Murakami T, Kim T, Gotoh M etal. Experimental hepatic dysfunction: evaluation by MR imaging with Gd-EOB-DTPA. Acad Radiol 1998; 5: 80-2.
9. Schmitz SA, Mühler A, Wagner S, Wolf KJ. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats. Invest Radiol 1996; 31: 154-60.
10. Ryeom HK, Kim SH, Kim JY etal. Quantitative evaluation of liver function with MRI using Gd-EOB-DTPA. Korean J Radiol 2004; 5: 231-9.
11. Tsuda N, Okada M, Murakami T. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. Eur J Radiol 2010; 73: 137-42.
12. Motosugi U, Ichikawa T, Sou H etal. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA- enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 2009; 30: 1042-46.
13. Nishie A, Ushijima Y, Tajima T etal. Quantitative analysis of liver function using superparamagnetic iron oxide- and Gd-EOB-DTPA-enhanced MRI: comparison with Technetium-99 m galactosyl serum albumin scintigraphy. Eur J Radiol 2011; [Epub ahead of print].
14. Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 2008; 18: 1577-86.
15. Nilsson H, Blomqvist L, Douglas L, Nordell A, Jonas E. Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB (Oxford) 2010; 12: 567-76.
16. Nilsson H, Nordell A, Vargas R, Douglas L, Jonas E, Blomqvist L. Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI. J Magn Reson Imaging 2009; 29: 1323-31.
17. Matsumata T, Kanematsu T, Yoshida Y, Furuta T, Yanaga K, Sugimachi K. The indocyanine green test enables prediction of postoperative complications after hepatic resection. World J Surg 1987; 11: 678-81.
18. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997; 84: 1255-9.
19. Ishikawa M, Yogita S, Miyake H etal. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma. Hepatogastroenterology 2002; 49: 1625-31.
20. Kokudo N, Vera DR, Makuuchi M. Clinical application of TcGSA. Nucl Med Biol 2003; 30: 845-9.
21. Ichida F, Tsuji T, Omata M etal. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996; 6: 112-9.
22. Makuuchi M, Imamura H, Sugawara Y, Takayama T. Progress in surgical treatment of hepatocellular carcinoma. Oncology 2002; 62: 74-81.
23. Harbin WP, Robert NJ, Ferrucci JT Jr. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology 1980; 135: 273-83.
24. Jonas E, Hultcrantz R, Slezak P, Blomqvist L, Schnell PO, Jacobsson H. Dynamic 99Tcm-HIDA SPET: non-invasive measuring of intrahepatic bile flow. Description of the method and a study in primary sclerosing cholangitis. Nucl Med Commun 2001; 22: 127-34.
25. Garcia JE, Atkins F. A low right-to-left hepatic lobe ratio. Is streamlining of ethanol to the right lobe of the liver the cause? Clin Nucl Med 1985; 10: 807-9.
26. Merriman RB, Ferrell LD, Patti MG etal. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006; 44: 874-80.
27. Jacobsson H, Jonas E, Hellström PM, Larsson SA. Different concentrations of various radiopharmaceuticals in the two main liver lobes: a preliminary study in clinical patients. J Gastroenterol 2005; 40: 733-8.
28. Aburano T, Taniguchi M, Hisada K, Miyazaki Y, Kakuma K, Fujioka M. Discordant hepatic uptake of Tc-99 m HIDA and Tc-99 m colloid in a patient with segmental biliary obstruction. Clin Nucl Med 1988; 13: 599-601.